Company facts
- Industry
- Pharmaceutical Preparations
- Headquarters
- South San Francisco, California
- Most recent report
- 8-K, filed Aug 28, 2026
- Filings on record
- 1,001+ filings
- On EDGAR
- CIK 1061983
- Fiscal year ends
- December
- Filer status
- Large accelerated filer
Financials 8 of 24
News 8 of 143
Prospectuses and Registrations 8 of 17
- S-8 Registration statement for an employee plan May 27, 2026
- 424B5 Prospectus supplement for an offering May 7, 2026
- 424B5 Prospectus supplement for an offering May 5, 2026
- S-8 Registration statement for an employee plan Feb 26, 2026
- S-8 Registration statement for an employee plan Aug 7, 2025
- S-3ASR Automatic shelf registration Feb 27, 2025
- S-8 Registration statement for an employee plan Jun 3, 2024
- 424B5 Prospectus supplement for an offering May 24, 2024
Proxies 8
- DEF 14A Proxy statement for a shareholder vote Apr 17, 2026
- DEF 14A Proxy statement for a shareholder vote Apr 10, 2025
- PRE 14A Preliminary proxy statement Mar 31, 2025
- DEF 14A Proxy statement for a shareholder vote Apr 8, 2024
- DEF 14A Proxy statement for a shareholder vote Apr 7, 2023
- PRE 14A Preliminary proxy statement Mar 27, 2023
- DEF 14A Proxy statement for a shareholder vote Apr 8, 2022
- DEF 14A Proxy statement for a shareholder vote Apr 7, 2021
Ownership 8 of 797
- 4 Insider reported a trade Sep 8, 2026
- 4 Insider reported a trade Sep 1, 2026
- 144 Notice of a proposed sale of restricted stock Sep 1, 2026
- 4 Insider reported a trade Aug 31, 2026
- 4 Insider reported a trade Aug 31, 2026
- 4 Insider reported a trade Aug 18, 2026
- SCHEDULE 13G/A Large holder reported a passive stake, amended Aug 13, 2026
- 4 Insider reported a trade Aug 10, 2026
Other 8 of 12
- ARS Annual report sent to shareholders Apr 17, 2026
- UPLOAD Comment letter from SEC staff Aug 13, 2025
- CORRESP Reply to SEC staff Aug 8, 2025
- UPLOAD Comment letter from SEC staff Jul 29, 2025
- ARS Annual report sent to shareholders Apr 10, 2025
- ARS Annual report sent to shareholders Apr 8, 2024
- ARS Annual report sent to shareholders Apr 7, 2023
- UPLOAD Comment letter from SEC staff Oct 26, 2021
Everything here comes from Cytokinetics Inc's own filings on SEC EDGAR. The filing list is rechecked every hour.